Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis

Abstract Background Checkpoint inhibitor pneumonitis (CIP) that develops following immune checkpoint inhibitor (ICI) treatment can be difficult to distinguish from other common etiologies of lung inflammation in cancer patients. Here, we evaluate the bronchoalveolar lavage fluid (BAL) for potential...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Michelle Ploch, Songzhu Zhao, Lai Wei, Joshua A. Englert, Sarah P. Cohen, Morgan A. Inks, Alexa S. Meara, Lynn A. Fussner, Dwight H. Owen, Kevin Ho
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Springer 2025-01-01
coleção:	Cancer Immunology, Immunotherapy
Assuntos:	Immune checkpoint inhibitor pneumonitis cancer immunotherapy
Acesso em linha:	https://doi.org/10.1007/s00262-024-03902-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!